Recommendations for risk stratified use of cardiac computed tomography for congenital heart disease during the COVID-19 pandemic

The impact of the coronavirus disease (COVID-19) pandemic in the United States and around the world has required significant changes to medical practice. Amidst the rapidly evolving public health emergency, hospital centers have been required to postpone elective procedures, preserve personal protec...

Descripción completa

Detalles Bibliográficos
Autores principales: Farooqi, Kanwal M., Ghoshhajra, Brian B., Shah, Amee M., Chelliah, Anjali, Einstein, Andrew J., Hlavacek, Anthony, Han, B. Kelly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Cardiovascular Computed Tomography. Published by Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282780/
https://www.ncbi.nlm.nih.gov/pubmed/32565094
http://dx.doi.org/10.1016/j.jcct.2020.06.003
Descripción
Sumario:The impact of the coronavirus disease (COVID-19) pandemic in the United States and around the world has required significant changes to medical practice. Amidst the rapidly evolving public health emergency, hospital centers have been required to postpone elective procedures, preserve personal protective equipment (PPE), practice social distancing and limit staff exposures. Patients with congenital heart disease (CHD) often need urgent evaluation, most commonly for preprocedural evaluation. We have stratified the most common indications for cardiac computed tomography (CCT) imaging in patients with CHD to help guide care for these patients during the COVID-19 pandemic including considerations for reopening.

Ejemplares similares